Effect of indomethacin in two siblings with a renin-dependent hypertension, hyperaldosteronism and hypokalemia.
Two siblings are described with hypertension, hyperreninism, hyperaldosteronism and hypokalemia. Propranolol therapy lowered blood pressure markedly, but failed to normalize serum potassium. Indomethacin orally decreased blood pressure and normalized all biochemical abnormalities. We suggest that in these patients there exists a renin-dependent hypertension in combination with a state of hyperprostaglandinism. It is likely from our studies in these 2 patients, that the state of hyperprostaglandinism is secondary to a hypertension with increased sympathetic tone.
D000293:Adolescent; D000328:Adult; D000804:Angiotensin II; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D007008:Hypokalemia / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D011433:Propranolol / Q000627:therapeutic use; D011453:Prostaglandins / Q000502:physiology*; D012083:Renin / Q000097:blood*; D012504:Saralasin / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013577:Syndrome
D011453:Prostaglandins; D000804:Angiotensin II; D013148:Spironolactone; D011433:Propranolol; D012083:Renin; D012504:Saralasin; D007213:Indomethacin